[Antibacterial effectiveness of long-acting isoniazid in the experiment]
- PMID: 9235596
[Antibacterial effectiveness of long-acting isoniazid in the experiment]
Abstract
The therapeutical efficiency of the long-acting lysosomotropic, complex drug isoniazid (LALCI) was tested in vivo and its antibacterial activity was studied in vitro. LALCI treatment of mice inoculated by virulent Mycobacterium tuberculosis was found to increase their life by 33% as compared with isoniazid. The findings suggest that the higher antibacterial effect of LALCI was due to the dextran matrix that potentiates the antibacterial activity of macrophages by acting on phagosomal and lysosomal cohesion.
Similar articles
-
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.Int J Tuberc Lung Dis. 2003 Jun;7(6):575-9. Int J Tuberc Lung Dis. 2003. PMID: 12797701
-
Isoniazid activity is terminated by bacterial persistence.J Infect Dis. 2007 Jun 15;195(12):1871-2; author reply 1872-3. doi: 10.1086/518046. J Infect Dis. 2007. PMID: 17492605 No abstract available.
-
[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].Probl Tuberk Bolezn Legk. 2004;(3):32-7. Probl Tuberk Bolezn Legk. 2004. PMID: 15338898 Russian.
-
Persistence, not resistance, is the cause of loss of isoniazid effect.J Infect Dis. 2007 Jun 15;195(12):1870-1; author reply 1872-3. doi: 10.1086/518044. J Infect Dis. 2007. PMID: 17492604 No abstract available.
-
New approaches to the treatment of latent tuberculosis.Semin Respir Crit Care Med. 2008 Oct;29(5):532-41. doi: 10.1055/s-0028-1085704. Epub 2008 Sep 22. Semin Respir Crit Care Med. 2008. PMID: 18810686 Review.
Cited by
-
Targeting the C-type lectins-mediated host-pathogen interactions with dextran.J Pharm Pharm Sci. 2014;17(3):371-92. doi: 10.18433/j3n590. J Pharm Pharm Sci. 2014. PMID: 25224349 Free PMC article. Review.